ERK1/2 Phosphorylation Predicts Survival in Recurrent Glioblastoma Following Intracerebral and Adjuvant PD-1/CTLA-4 Immunotherapy: A REMARK-guided Analysis.
Article in Clinical Cancer Research (November 2023)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Article in Clinical Cancer Research (November 2023)
Article in Frontiers in Oncology (August 2023)
Article in World Journal of Gastroenterology (August 2022)